April 8, 2026 The post Sidewinder Therapeutics Announces $137 Million Series B Financing to Advance Precision Bispecific ADCs into Clinical Development for Cancer first appeared on Sidewinder Therapeutics .
Need help?
Contact usApril 8, 2026 The post Sidewinder Therapeutics Announces $137 Million Series B Financing to Advance Precision Bispecific ADCs into Clinical Development for Cancer first appeared on Sidewinder Therapeutics .